Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 15.15

From 52W high−24.75%

Volume8.91M

Market capCNY 26.46B

P/E (TTM)20.6x

P/S (TTM)3.2x

Div yield5.26%

Key dataSep 18, 2026

Open

CNY 15.15

From 52W high

−24.75%

Volume

8.91M

Market cap

CNY 26.46B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.0x

P/E (TTM)

20.6x

RSI (14)

38.1

MomentumView details →

1D Return

−3.71%

YTD Return

−10.95%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

20.6x

EV/EBITDA

11.0x

EV/Sales

3.1x

P/S (TTM)

3.2x

P/B (TTM)

2.5x

ProfitabilityView details →

Gross Margin

66.09%

Net Margin

17.31%

EBITDA Margin

28.35%

ROE (TTM)

12.01%

ROA (TTM)

9.66%

Asset Turnover

0.57x

GrowthView details →

Revenue YoY

+24.64%

EPS YoY

+294.90%

FCF YoY

+214.53%

Revenue CAGR 3Y

−14.51%

EPS CAGR 3Y

−18.34%

EBITDA YoY

—

MomentumView details →

1D Return

−3.71%

YTD Return

−10.95%

1Y Return

−7.65%

RSI (14)

38.1

vs 50D SMA

−7.28%

vs 200D SMA

−9.34%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

2.50x

Quick Ratio

1.92x

Div Yield

5.26%

Div Rate

CNY 0.80

Div Growth 1Y

+66.67%

EarningsView details →

EPS (Actual)

CNY 0.21

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

7.91B

Net Income (TTM)

1.37B

Op. CF (TTM)

2.05B

Next earningsOct 23, 2026 →

Latest newsMore news →

China's 2026 National Essential Medicines List took effect on September 1, adding 116 new drugs including four domestic Class 1 innovative drugs and Novo Nordisk's semaglutide.20d ago

Yiling Pharmaceutical announced its first-half 2026 results with revenue of 4.075 billion yuan, net profit of 757 million yuan, and no dividend distribution.23d ago

Similar companies

涛涛车业301345.SZ 山子高科000981.SZ 国恩股份002768.SZ 大金重工002487.SZ 景嘉微300474.SZ 鱼跃医疗002223.SZ Find similar companies →

Latest newsMore news →

China's 2026 National Essential Medicines List took effect on September 1, adding 116 new drugs including four domestic Class 1 innovative drugs and Novo Nordisk's semaglutide.20d ago Yiling Pharmaceutical announced its first-half 2026 results with revenue of 4.075 billion yuan, net profit of 757 million yuan, and no dividend distribution.23d ago